Premier Alternatives

Gregor Diagnostics

Madison, WI · Founded 2016 · Privately Held (backing)

Operator of a molecular diagnostics company intended to develop a novel screening test for prostate cancer. Gregor Diagnostics is based in Madison, WI and was founded in 2016. Its last reported valuation was $9.5 million in Oct 2021. It has raised $14.6 million across 4 recorded rounds; the latest was a $4.4 million seed round in Mar 2023.

Last reported valuation
$9.5M
Oct 2026
Priced at
—
Total raised
$14.6M
Last round
Seed Round
Mar 2023

Gregor Diagnostics key facts

as of Oct 2026
  • Operator of a molecular diagnostics company intended to develop a novel screening test for prostate cancer.
  • Gregor Diagnostics is valued at approximately $9.5M as of Oct 2026 (last reported valuation).
  • It has raised $14.6M across 4 recorded rounds; the latest was Seed Round ($4.4M) in Mar 2023.
  • Notable investors include First Round Capital, gBETA, Zachary Weinberg, Wisconsin Economic Development, WARF Ventures — 9 tracked in total.
  • Gregor Diagnostics has filed 4 Form Ds with the SEC since 2018, most recently Oct 2023 ($4.4M sold to 4 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$9.5M

Gregor Diagnostics's last reported valuation, Oct 2021. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Gregor Diagnostics with a free account
  • ·Watch Gregor Diagnostics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Gregor Diagnostics funding rounds

4 rounds
Mar 2023Seed Round$4.4MSEC filing▮
Oct 2021Early Stage VC$5.0MSEC filing▮
Oct 2019Seed Round$916KSEC filing▮
Jun 2018Seed Round$900KSEC filing▮
Full funding history →

Gregor Diagnostics valuation

Gregor Diagnostics's last reported valuation was $9.5 million in Oct 2021. No priced round, secondary trade or fund mark has surfaced since.

How much has Gregor Diagnostics raised?

Gregor Diagnostics has raised $14.6 million across 4 recorded rounds since 2018. The largest was a $915,667 seed round in Oct 2019; the most recent was a $4.4 million seed round in Mar 2023.

Gregor Diagnostics has filed 4 Form Ds with the SEC since 2018, most recently in Oct 2023 ($4.4 million sold to 4 investors).

Gregor Diagnostics investors

9 investors are on record for Gregor Diagnostics, including First Round Capital, gBETA, Zachary Weinberg and Wisconsin Economic Development. The seed round in Mar 2023 drew 4 investors.

About Gregor Diagnostics

Operator of a molecular diagnostics company intended to develop a novel screening test for prostate cancer. The company's cancer test is created using seminal fluid as a sample source, can detect prostate cancer at the earliest stages of the disease and differentiate between indolent and aggressive cancer, enabling physicians to reduce overdiagnosis and overtreatment of indolent prostate cancer and more effectively detect and management of aggressive prostate cancer.

Sector
Healthcare
HQ
Madison, WI, United States
Founded
2016
Employees
8
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.